LaChapelle Robin
Insider CIK 2009136 · AVBP Chief Operating Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| AVBP ArriVent BioPharma, Inc. | M Exercise deriv | 2026-10-30 | 2026-11-02 | 17,648 | — | $0 | 38,823 | SEC↗ |
| AVBP ArriVent BioPharma, Inc. | M Exercise deriv | 2026-10-30 | 2026-11-02 | 16,265 | — | $0 | 2,600 | SEC↗ |
| AVBP ArriVent BioPharma, Inc. | M Exercise deriv | 2026-10-30 | 2026-11-02 | 1,820 | — | $0 | 0 | SEC↗ |
| AVBP ArriVent BioPharma, Inc. | M Exercise deriv | 2026-10-30 | 2026-11-02 | 4,550 | — | $0 | 1,820 | SEC↗ |
| AVBP ArriVent BioPharma, Inc. | M Exercise deriv | 2026-10-30 | 2026-11-02 | 410 | — | $0 | 0 | SEC↗ |
| AVBP ArriVent BioPharma, Inc. | M Exercise | 2026-10-30 | 2026-11-02 | 17,648 | $6.24 | $110.1K | 176,429 | SEC↗ |
| AVBP ArriVent BioPharma, Inc. | M Exercise | 2026-10-30 | 2026-11-02 | 1,820 | $2.28 | $4.2K | 158,781 | SEC↗ |
| AVBP ArriVent BioPharma, Inc. | M Exercise | 2026-10-30 | 2026-11-02 | 4,550 | $2.28 | $10.4K | 156,961 | SEC↗ |
| AVBP ArriVent BioPharma, Inc. | M Exercise | 2026-10-30 | 2026-11-02 | 410 | $2.28 | $935 | 152,411 | SEC↗ |
| AVBP ArriVent BioPharma, Inc. | M Exercise | 2026-10-30 | 2026-11-02 | 16,265 | $3.65 | $59.4K | 152,001 | SEC↗ |
| AVBP ArriVent BioPharma, Inc. | A Award deriv | 2026-02-02 | 2026-02-04 | 130,000 | — | $0 | 130,000 | SEC↗ |
| AVBP ArriVent BioPharma, Inc. | M Exercise deriv | 2025-07-11 | 2025-07-15 | 2,050 | — | $0 | 410 | SEC↗ |
| AVBP ArriVent BioPharma, Inc. | M Exercise deriv | 2025-07-11 | 2025-07-15 | 6,503 | — | $0 | 6,370 | SEC↗ |
| AVBP ArriVent BioPharma, Inc. | M Exercise deriv | 2025-07-11 | 2025-07-15 | 2,600 | — | $0 | 12,873 | SEC↗ |
| AVBP ArriVent BioPharma, Inc. | M Exercise | 2025-07-11 | 2025-07-15 | 2,600 | $2.28 | $5.9K | 129,233 | SEC↗ |
| AVBP ArriVent BioPharma, Inc. | M Exercise | 2025-07-11 | 2025-07-15 | 6,503 | $2.28 | $14.8K | 135,736 | SEC↗ |
| AVBP ArriVent BioPharma, Inc. | M Exercise | 2025-07-11 | 2025-07-15 | 2,050 | $2.28 | $4.7K | 126,633 | SEC↗ |
| AVBP ArriVent BioPharma, Inc. | A Award deriv | 2025-02-03 | 2025-02-14 | 120,000 | — | $0 | 120,000 | SEC↗ |
| AVBP ArriVent BioPharma, Inc. | M Exercise deriv | 2024-09-19 | 2024-09-23 | 2,700 | — | $0 | 56,471 | SEC↗ |
| AVBP ArriVent BioPharma, Inc. | M Exercise deriv | 2024-09-19 | 2024-09-23 | 12,364 | — | $0 | 18,865 | SEC↗ |
| AVBP ArriVent BioPharma, Inc. | M Exercise deriv | 2024-09-19 | 2024-09-23 | 7,164 | — | $0 | 15,473 | SEC↗ |
| AVBP ArriVent BioPharma, Inc. | M Exercise deriv | 2024-09-19 | 2024-09-23 | 2,867 | — | $0 | 22,637 | SEC↗ |
| AVBP ArriVent BioPharma, Inc. | M Exercise deriv | 2024-09-19 | 2024-09-23 | 2,471 | — | $0 | 2,460 | SEC↗ |
| AVBP ArriVent BioPharma, Inc. | M Exercise | 2024-09-19 | 2024-09-23 | 2,867 | $2.28 | $6.5K | 102,584 | SEC↗ |
| AVBP ArriVent BioPharma, Inc. | M Exercise | 2024-09-19 | 2024-09-23 | 2,700 | $6.24 | $16.8K | 99,717 | SEC↗ |
| AVBP ArriVent BioPharma, Inc. | M Exercise | 2024-09-19 | 2024-09-23 | 7,164 | $2.28 | $16.3K | 109,748 | SEC↗ |
| AVBP ArriVent BioPharma, Inc. | M Exercise | 2024-09-19 | 2024-09-23 | 12,364 | $3.65 | $45.1K | 124,583 | SEC↗ |
| AVBP ArriVent BioPharma, Inc. | M Exercise | 2024-09-19 | 2024-09-23 | 2,471 | $2.28 | $5.6K | 112,219 | SEC↗ |